t.demir
TL2 · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 13 March 2025 · last posted 2d
70Posts here
0Topics
0Solutions
1kLikes received
683Likes given
19Badges
198Days visited
3.2kPosts read
Recent activity
Full stream-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #73 · Practice › Interactions · 26 Jul 2026 · 23 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on Delayed gastric emptying and…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #75 · Practice › Administration · 23 Jul 2026 · 21 likes Completing a dose was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Follow-up: Sleep quality changes during weight loss Replied, post #75 · Wellbeing › Sleep · 21 Jul 2026 · 33 likes Post #73 and I disagree about the size of the effect, not about the direction. A referral for a proper sleep study answers in one night what months of forum discussion…
-
Sleep quality changes during weight loss Replied, post #20 · Wellbeing › Sleep · 16 Jul 2026 · 17 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #23 · Outcomes › Progress reports · 9 Jul 2026 · 30 likes This follows post #22 rather than contradicting it. Rate of change matters more than the absolute number for most of the questions people ask about their own series.
-
[2026 update] Documenting an adverse event properly Replied, post #3 · Safety › Adverse events · 7 Jul 2026 · 17 likes Everything in the opening post holds. The case it does not cover is the one I have. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #40 · Access › Pricing · 6 Jul 2026 · 0 likes Taking post #37 at face value and following it one step further. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That…
-
Coming back to: Telehealth prescribing models in the US Replied, post #7 · Regional › North America · 6 Jul 2026 · 27 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different. That is the version I use. It may not be the version…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #65 · Start Here › Welcome · 6 Jul 2026 · 24 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #57 · Analytics › Home & field testing · 6 Jul 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #22 · Compounds › Retatrutide · 28 Jun 2026 · 26 likes On post #18 — agreed on the reasoning, with one qualification. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an…
-
Injection volume, overload, and peak distortion Replied, post #6 · Analytics › HPLC & UHPLC · 13 May 2026 · 5 likes Post #2 put the caveat in the right place and I want to underline it. Distinguishing three things in the injection volume discussion that keep getting used…